Circulating biomolecules identify patients with atrial fibrillation at high risk of cardiovascular events

Medicine Research News News

Circulating biomolecules identify patients with atrial fibrillation at high risk of cardiovascular events
Medicine ResearchHealth Research NewsHealth Research
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 45 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 38%
  • Publisher: 51%

An analysis of the biomolecule substudy of the EAST–AFNET 4 trial has revealed that biomolecule concentrations in the blood of patients with atrial fibrillation can be used to identify patients at high and low cardiovascular risk. The findings were published in Cardiovascular Research.

Circulating biomolecules identify patients with atrial fibrillation at high risk of cardiovascular eventsAn analysis of the biomolecule substudy of the EAST–AFNET 4 trial has revealed that biomolecule concentrations in the blood of patients with atrial fibrillation can be used to identify patients at high and low cardiovascular risk.Atrial Fibrillation is the most common arrhythmia in elderly people. AF often occurs in patients with cardiovascular comorbidities with shared disease mechanisms.

Paulus Kirchhof, principal investigator of EAST–AFNET 4 and author on the paper, explained,"We were fortunate that we precisely could quantify thirteen biomolecules related to different disease processes in the EAST–AFNET 4 The highest-risk patient cluster mainly showed cardiometabolic disturbances, with elevated concentrations of the biomolecules BMP10, IGFBP7, NT-proBNP, ANGPT2 and GDF15. Patients in the lowest-risk cluster showed low concentrations of these biomolecules.

"Our findings call for future research into the effects of biomolecules on cardiovascular function. These patient clusters open new treatment options in each: Circulating biomolecules identify patients with atrial fibrillation at high risk of cardiovascular events retrieved 15 April 2024 from https://medicalxpress.com/news/2024-04-circulating-biomolecules-patients-atrial-fibrillation.html

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

medical_xpress /  🏆 101. in UK

Medicine Research Health Research News Health Research Health Science Medicine Science

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Train strikes hit east and south-east England bringing commuter chaosTrain strikes hit east and south-east England bringing commuter chaosSome train operators will be running no services at all today.
Read more »

Train strikes hit east and south-east England bringing commuter chaosTrain strikes hit east and south-east England bringing commuter chaosSome train operators will be running no services at all today.
Read more »

Bio-Rad launches validated antibodies for rare cell and circulating tumor cell enumerationBio-Rad launches validated antibodies for rare cell and circulating tumor cell enumerationAntibodies validated for use with Bio-Rad’s Celselect Slides™ enumeration stain kits to enable immunostaining of captured circulating tumor cells in liquid biopsy samples.
Read more »

Revealing characteristics of circulating cell-free RNA in the blood of liver cancer patientsRevealing characteristics of circulating cell-free RNA in the blood of liver cancer patientsRecently, the research findings of the team led by CAS Academician Xiang Zhou from Wuhan University were published in the National Science Review. The team successfully developed an efficient technique for enriching trace amounts of circulating nucleic acids in blood.
Read more »

Jake Paul slams 'leaked rules' for Mike Tyson fight with video circulating on social mediaJake Paul slams 'leaked rules' for Mike Tyson fight with video circulating on social mediaJake Paul has responded to a series of alleged rules for his fight against Mike Tyson that are circulating online.
Read more »

Circulating tumor DNA levels predict outcomes for gastroesophageal cancer treated with immunotherapyCirculating tumor DNA levels predict outcomes for gastroesophageal cancer treated with immunotherapyMonitoring levels of DNA shed by tumors and circulating in the bloodstream could help doctors accurately assess how gastroesophageal cancers are responding to treatment, and potentially predict future prognosis, suggests a new study led by researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg–Kimmel Institute for Cancer...
Read more »



Render Time: 2025-02-22 16:01:00